Correction: Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events

Related Posts

• Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events

  Background Management of immune-related adverse events (irAEs) is important as they cause treatment interruption or…

• Correction: Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models

• New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma

  Background Progress in breast cancer (BC) research relies on the availability of suitable cell lines…